Faeth Therapeutics CFO Brian C. Stephenson purchased 831 shares for $19,395.54 at $23.34, marking the largest purchase of his career and signaling confidence in the stock's current valuation.
Price context
The stock is trading at $23.345, down 10.21% over the last 5 days but up 18.14% over the last 30 days, and sits 27.5% below its 52-week high of $32.2.
Catalysts to watch
Coming off a career-grade D rating, the insider's largest-ever purchase serves as a catalyst; additionally, the stock is up 15% over the last month as noted in Simply Wall St.'s October 22, 2025 report.
Risks
The stock is currently down 10.21% in the last 5 days, indicating recent selling pressure that could persist despite the insider purchase.
AI-generated context from public data. Not investment advice. Verify before trading.